Once high short data collides with a significant catalyst the possibility of a short squeeze skyrockets. This might be the case for struggling Novavax, Inc. (NASDAQ: NVAX) which faces the risk of filing for bankruptcy due to the waning demand for Covid vaccines. With this in mind, NVAX’s Covid vaccine was recently endorsed by the EMA for full approval which...
NVAX hit a swing low to open the week and has celebrated federal actions
related to vaccine development with the current uptrend. Having a bit of a
pullback, I see room for an entry. Other vaccine stocks have ad a good week
notably MRNA. This further supports an entry here as buyers from earlier
in the week take their profits. NVAX has been heavily...
NVAX is fundamentally weak with a shallow pipeline and no products currenly marketed
to fund earnings and so research. On the 15 minute chart , NVAX is seen near to its
demand zone as shown by the Luxalgo indicator. In the meanwhile, the RSI indicator
shows considerable recent strength which is decreased today.
So the question is whether NVAX can dead...
Not financial advice.
The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
NVAX as seen on the weekly chart has been in price distress for a long time.
It has only one product on the market due to various issues with the FDA process.
It has a variety of products in development as linked below.
The question is whether it will run out of cash before a sustained revenue
stream develops. FDA approvals for the pipeline products could take...
Hi guys, NVAX showed up on my feed today as down 25% so I decided to take a look. What I see is a text book Bearish Shark attack on the stock. Looking at the embedded image in this chart you can compare the events as they occurred. The stock price has also gone back to beginning of the rally.
Please do your DD this is not a financial advice.
If it can complete a structure I am looking for then it can potentially run to 30s best case, but more likely 19-22. Worst case it has downside risk to 4 if this structure falls apart.
Rejection from re-entering blue channel would imply the latter. Good news would be necessary for the best case.
The more likely case is just a technical gap fill - would happen...
Novavax - 30d expiry - We look to Sell at 27.69 (stop at 30.03)
The primary trend remains bearish.
Trading within a Corrective Channel formation.
The trend of higher highs is located at 26.80.
Previous support at 27.40 now becomes resistance.
We look for a temporary move higher.
Preferred trade is to sell into rallies.
Our profit targets will be 22.02 and...
Novavax - 30d expiry - We look to Sell a break of 15.49 (stop at 17.01)
Daily signals are bearish.
There is no clear indication that the downward move is coming to an end.
Prices are extending lower from the bearish flag/pennant formation.
Posted a bearish Flag formation.
A break of 15.50 is needed to confirm the outlook.
The bias is to break to the...
Accumulation or distribution? Wychoff wants to know! Phase C, Spring Stage? M.Cap is below CASH, Best in Class vaccine with over 43+ International Approvals.
It’s just amazing what Nova’s teams have be able to accomplish(for its size) around the globe!
Near term (1-2 weeks): target range 25-28
1-2 months: 45 range
Goal target (Q1 or Q2 2023): 163
Historical pattern is cyclical, with 7 completed alternating cycles between 20 and >=163
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a...
Short Term
We look to Buy at 30.75 (stop at 26.75)
Bullish Outside Day posted, a pattern that often indicates the end of a bearish run and the start of a new upward bias. Prices have continued the bullish move higher and resulted in 3 consecutive positive days. Although the bears are in control, the stalling negative momentum indicates a turnaround is...
Update on Wyckoff accumulation chart. Volume is decreasing. A low-volume spring (or a low-volume test of a shakeout) indicates that the stock is likely to be ready to move up, so this is a good time to initiate at least a partial long position.
